Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

10,370

Employees10,370

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

10,370

Employees10,370

ILMN Key Statistics

Market cap

15.52B

Market cap15.52B

Price-Earnings ratio

12.05

Price-Earnings ratio12.05

Dividend yield

—

Dividend yield—

Average volume

1.31M

Average volume1.31M

High today

$101.01

High today$101.01

Low today

$95.20

Low today$95.20

Open price

$95.31

Open price$95.31

Volume

1.78M

Volume1.78M

52 Week high

$156.66

52 Week high$156.66

52 Week low

$68.70

52 Week low$68.70

ILMN News

Simply Wall St 2d

How Investors May Respond To Illumina Launching Protein Prep to Advance Multiomics Strategy

Illumina recently announced the global launch of Illumina Protein Prep, a next-generation sequencing-based proteomics assay that enables researchers worldwide t...

Analyst ratings

50%

of 26 ratings

Buy

38.5%

Hold

50%

Sell

11.5%

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.